In glioblastoma, markers of tumor progression include the expression of proliferating cell nuclear antigen (PCNA), enhancer of zeste homolog 2 (EZH2) and ionic transporters that regulate intracellular chloride levels [9,10,11]. This evidence concerns the gene EZH2 and neoplasm.